4163-77-3

Upstream product

• 4184-49-0 Monothiophosphorsaeure-O,O-dimethylester-S-<2-methoxy-4-nitro-phenylester> 
• 1009-36-5 2-chloro-5-nitroanisole 
• 90196-42-2 2-Methoxy-4-nitro-phenyl-thiocyanat 
• 4184-41-2 Bis-<2-methoxy-4-nitro-phenyl>-disulfid 
• 3908-55-2 Trimethyl(methylthio)silane 
• 5458-84-4 2-iodo-5-nitroanisole 
• 5188-07-8 sodium thiomethoxide 
• 315228-80-9 2-methoxy-4-nitrobenzenethiol 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 861339-82-4 2-methoxy-1-(methylsulfinyl)-4-nitrobenzene 
• 75259-31-3 3-methoxy-4-(methylsulfonyl)aniline 
• 75259-30-2 2-methoxy-1-(methylsulfonyl)-4-nitrobenzene 

Relevant academic research and scientific papers

FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS

The present invention relates broadly to functionalised and substituted indoles, the preparation thereof and their use in the treatment of proliferative diseases such as cancer.

Efficient synthesis of aryl methyl sulfide derivatives using (methylthio)trimethylsilane as methylthiolation reagent

The synthesis of various aryl methyl sulfides has been achieved by treatment of nitroarenes with a combination of (methylthio)trimethylsilane and cesium carbonate in dimethylsulfoxide. This reaction gives access to aryl methyl sulfide derivatives in high yields. Copyright

DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS

Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.